| Theresa Lacava, MD | |
|
86 Mcclellandtown Rd, Uniontown, PA 15401-5527 | |
| (724) 430-7990 | |
| (724) 430-7993 |
| Full Name | Theresa Lacava |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 34 Years |
| Location | 86 Mcclellandtown Rd, Uniontown, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063412088 | NPI | - | NPPES |
| 000833D4Z | Other | PA | HGSA MEDICARE |
| 75016 | Other | PA | MEDPLUS |
| P001082 | Other | PA | GATEWAY |
| 139508 | Other | PA | HIGHMARK |
| 080143282 | Other | PA | RAILROAD MEDICARE |
| 1115189 | Other | PA | UPMC |
| 0016639200009 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 063299L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Monongahela Valley Hospital | Monongahela, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mon Vale Clinical Professionals Inc | 4385941012 | 30 |
News Archive
As the United States moves toward the goal of a secure nationwide health information network, a new study from the Regenstrief Institute provides a framework for evaluating the costs, effort and value of what is sometimes referred to as the health internet.
According to data presented at the National Kidney Foundation's (NKF) 2006 clinical meeting in Chicago, IL, a conversion to the non-calcium phosphate binder FOSRENOL (lanthanum carbonate) from other phosphate binder therapies provides continued mean serum phosphorus control for end-stage renal disease (ESRD) patients with hyperphosphatemia, while significantly reducing their daily tablet burden and the total daily dose of phosphate binder medication.
From tele-monitoring patients with diabetes to using artificial intelligence to prevent sepsis, the newly launched Center for Health Innovation at UC San Diego Health will seek to develop, test and commercialize technologies that make a real, measurable difference in the lives and wellbeing of patients.
Global Information Inc. announces the addition of a new market research report "Cancer Profiling and Pathways: Technologies and Global Markets" at GIIResearch.com.
Biogen Idec and Elan Corporation, plc (NYSE: ELN) today announced six-month results of an ongoing, one-year longitudinal, observational, patient-reported outcomes study showing multiple sclerosis (MS) patients taking TYSABRI- (natalizumab) experienced an improvement in both their physical function and psychological well-being.
› Verified 5 days ago
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
As the United States moves toward the goal of a secure nationwide health information network, a new study from the Regenstrief Institute provides a framework for evaluating the costs, effort and value of what is sometimes referred to as the health internet.
According to data presented at the National Kidney Foundation's (NKF) 2006 clinical meeting in Chicago, IL, a conversion to the non-calcium phosphate binder FOSRENOL (lanthanum carbonate) from other phosphate binder therapies provides continued mean serum phosphorus control for end-stage renal disease (ESRD) patients with hyperphosphatemia, while significantly reducing their daily tablet burden and the total daily dose of phosphate binder medication.
From tele-monitoring patients with diabetes to using artificial intelligence to prevent sepsis, the newly launched Center for Health Innovation at UC San Diego Health will seek to develop, test and commercialize technologies that make a real, measurable difference in the lives and wellbeing of patients.
Global Information Inc. announces the addition of a new market research report "Cancer Profiling and Pathways: Technologies and Global Markets" at GIIResearch.com.
Biogen Idec and Elan Corporation, plc (NYSE: ELN) today announced six-month results of an ongoing, one-year longitudinal, observational, patient-reported outcomes study showing multiple sclerosis (MS) patients taking TYSABRI- (natalizumab) experienced an improvement in both their physical function and psychological well-being.
› Verified 5 days ago
| Entity Name | Centerville Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801877048 PECOS PAC ID: 7214837202 Enrollment ID: O20040427000681 |
News Archive
As the United States moves toward the goal of a secure nationwide health information network, a new study from the Regenstrief Institute provides a framework for evaluating the costs, effort and value of what is sometimes referred to as the health internet.
According to data presented at the National Kidney Foundation's (NKF) 2006 clinical meeting in Chicago, IL, a conversion to the non-calcium phosphate binder FOSRENOL (lanthanum carbonate) from other phosphate binder therapies provides continued mean serum phosphorus control for end-stage renal disease (ESRD) patients with hyperphosphatemia, while significantly reducing their daily tablet burden and the total daily dose of phosphate binder medication.
From tele-monitoring patients with diabetes to using artificial intelligence to prevent sepsis, the newly launched Center for Health Innovation at UC San Diego Health will seek to develop, test and commercialize technologies that make a real, measurable difference in the lives and wellbeing of patients.
Global Information Inc. announces the addition of a new market research report "Cancer Profiling and Pathways: Technologies and Global Markets" at GIIResearch.com.
Biogen Idec and Elan Corporation, plc (NYSE: ELN) today announced six-month results of an ongoing, one-year longitudinal, observational, patient-reported outcomes study showing multiple sclerosis (MS) patients taking TYSABRI- (natalizumab) experienced an improvement in both their physical function and psychological well-being.
› Verified 5 days ago
| Entity Name | Highlands Hospital And Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447443957 PECOS PAC ID: 2769460757 Enrollment ID: O20040707001195 |
News Archive
As the United States moves toward the goal of a secure nationwide health information network, a new study from the Regenstrief Institute provides a framework for evaluating the costs, effort and value of what is sometimes referred to as the health internet.
According to data presented at the National Kidney Foundation's (NKF) 2006 clinical meeting in Chicago, IL, a conversion to the non-calcium phosphate binder FOSRENOL (lanthanum carbonate) from other phosphate binder therapies provides continued mean serum phosphorus control for end-stage renal disease (ESRD) patients with hyperphosphatemia, while significantly reducing their daily tablet burden and the total daily dose of phosphate binder medication.
From tele-monitoring patients with diabetes to using artificial intelligence to prevent sepsis, the newly launched Center for Health Innovation at UC San Diego Health will seek to develop, test and commercialize technologies that make a real, measurable difference in the lives and wellbeing of patients.
Global Information Inc. announces the addition of a new market research report "Cancer Profiling and Pathways: Technologies and Global Markets" at GIIResearch.com.
Biogen Idec and Elan Corporation, plc (NYSE: ELN) today announced six-month results of an ongoing, one-year longitudinal, observational, patient-reported outcomes study showing multiple sclerosis (MS) patients taking TYSABRI- (natalizumab) experienced an improvement in both their physical function and psychological well-being.
› Verified 5 days ago
| Entity Name | Mon Vale Clinical Professionals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013388271 PECOS PAC ID: 4385941012 Enrollment ID: O20160324000444 |
News Archive
As the United States moves toward the goal of a secure nationwide health information network, a new study from the Regenstrief Institute provides a framework for evaluating the costs, effort and value of what is sometimes referred to as the health internet.
According to data presented at the National Kidney Foundation's (NKF) 2006 clinical meeting in Chicago, IL, a conversion to the non-calcium phosphate binder FOSRENOL (lanthanum carbonate) from other phosphate binder therapies provides continued mean serum phosphorus control for end-stage renal disease (ESRD) patients with hyperphosphatemia, while significantly reducing their daily tablet burden and the total daily dose of phosphate binder medication.
From tele-monitoring patients with diabetes to using artificial intelligence to prevent sepsis, the newly launched Center for Health Innovation at UC San Diego Health will seek to develop, test and commercialize technologies that make a real, measurable difference in the lives and wellbeing of patients.
Global Information Inc. announces the addition of a new market research report "Cancer Profiling and Pathways: Technologies and Global Markets" at GIIResearch.com.
Biogen Idec and Elan Corporation, plc (NYSE: ELN) today announced six-month results of an ongoing, one-year longitudinal, observational, patient-reported outcomes study showing multiple sclerosis (MS) patients taking TYSABRI- (natalizumab) experienced an improvement in both their physical function and psychological well-being.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Theresa Lacava, MD 1070 Old National Pike, Fredericktown, PA 15333-2114 Ph: (724) 632-6801 | Theresa Lacava, MD 86 Mcclellandtown Rd, Uniontown, PA 15401-5527 Ph: (724) 430-7990 |
News Archive
As the United States moves toward the goal of a secure nationwide health information network, a new study from the Regenstrief Institute provides a framework for evaluating the costs, effort and value of what is sometimes referred to as the health internet.
According to data presented at the National Kidney Foundation's (NKF) 2006 clinical meeting in Chicago, IL, a conversion to the non-calcium phosphate binder FOSRENOL (lanthanum carbonate) from other phosphate binder therapies provides continued mean serum phosphorus control for end-stage renal disease (ESRD) patients with hyperphosphatemia, while significantly reducing their daily tablet burden and the total daily dose of phosphate binder medication.
From tele-monitoring patients with diabetes to using artificial intelligence to prevent sepsis, the newly launched Center for Health Innovation at UC San Diego Health will seek to develop, test and commercialize technologies that make a real, measurable difference in the lives and wellbeing of patients.
Global Information Inc. announces the addition of a new market research report "Cancer Profiling and Pathways: Technologies and Global Markets" at GIIResearch.com.
Biogen Idec and Elan Corporation, plc (NYSE: ELN) today announced six-month results of an ongoing, one-year longitudinal, observational, patient-reported outcomes study showing multiple sclerosis (MS) patients taking TYSABRI- (natalizumab) experienced an improvement in both their physical function and psychological well-being.
› Verified 5 days ago
Dr. John C. Chalfant, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 202 Jacob Murphy Ln Ste 102, Uniontown, PA 15401 Phone: 724-437-8880 Fax: 724-437-0112 | |
Rachel Japitana Talaman-perez, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 Mary Higginson Ln, Suite 1, Uniontown, PA 15401 Phone: 724-430-5940 Fax: 724-430-3879 | |
Richard Cook, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Matthew Dr Ste 2001, Uniontown, PA 15401 Phone: 724-438-1808 Fax: 724-438-8799 | |
Dr. May R. Flores, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 30 Poplar Ln, Upper Level, Uniontown, PA 15401 Phone: 724-439-4800 Fax: 724-430-8967 | |
Tina Marie Keener, CRNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 86 Mcclellandtown Rd, Uniontown, PA 15401 Phone: 724-430-7990 | |
Rebecca David, NP-C Family Medicine Medicare: Medicare Enrolled Practice Location: 201 Mary Higginson Ln, Uniontown, PA 15401 Phone: 724-430-5940 |